FDA 483 - Biomay AG - July 27, 2023

An FDA inspection of Biomay AG in Vienna, Austria, identified two observations related to manufacturing practices. The firm was cited for not following contamination control procedures, including issues with equipment repair and storage of cleaning supplies. Additionally, the inspection found that equipment was not adequately qualified, specifically lacking an air visualization study for a critical manufacturing area.